Thromboxane synthase: Structure and function of protein and gene

Prostaglandins and Other Lipid Mediators

Volumn 68-69, Issue , 2002, Pages 409-422

  Wang, Lee Ho ^a   Kulmacz, Richard J ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Function; Gene; Structure; Thromboxane synthase

Indexed keywords

ENZYME VARIANT; HEME; ICOSANOID; THROMBOXANE SYNTHASE; PROSTAGLANDIN H; PROSTAGLANDIN H2; THROMBOXANE A2;

ARTICLE; ENZYME KINETICS; ENZYME MECHANISM; GENE EXPRESSION; GENETIC ANALYSIS; PROTEIN ANALYSIS; PROTEIN FUNCTION; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION; BINDING SITE; BIOSYNTHESIS; CHEMICAL STRUCTURE; CHEMISTRY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PROTEIN TERTIARY STRUCTURE; REVIEW;

BASE SEQUENCE; BINDING SITES; EICOSANOIDS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HEME; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROSTAGLANDIN H2; PROSTAGLANDINS H; PROTEIN STRUCTURE, TERTIARY; STRUCTURE-ACTIVITY RELATIONSHIP; THROMBOXANE A2; THROMBOXANE-A SYNTHASE;

EID: 0036669427     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00045-X     Document Type: Article

References (60)

1. Diczfalusy U., Falardeau P., Hammarstrom S. Conversion of prostaglandin endoperoxides to C17-hydroxy acids catalyzed by human platelet thromboxane synthase. FEBS Lett. 84:1977;271-274.
2. 2. Fed. Proc. 46:1987;133-138.
3. Murray R., FitzGerald G.A. Regulation of thromboxane receptor activation in human platelets. Proc. Natl. Acad. Sci. USA. 86:1989;124-128.
4. 2 receptor. Nature. 349:1991;617-620.
5. 2 from prostaglandin endoperoxides. Nature. 261:1976;558-560.
6. Haurand M., Ullrich V. Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme. J. Biol. Chem. 260:1985;15059-15067.
7. Yokoyama C., Miyata A., Ihara H., Ullrich V., Tanabe T. Molecular cloning of human platelet thromboxane A synthase. Biochem. Biophys. Res. Commun. 178:1991;1479-1484.
8. Ohashi K., Ruan K.H., Kulmacz R.J., Wu K.K., Wang L.H. Primary structure of human thromboxane synthase determined from the cDNA sequence. J. Biol. Chem. 267:1992;789-793.
9. Xia Z., Shen R.F., Baek S.J., Tai H.H. Expression of two different forms of cDNA for thromboxane synthase in insect cells and site-directed mutagenesis of a critical cysteine residue. Biochem. J. 295:1993;457-461.
10. Tanabe T., Ullrich V. Prostacyclin and thromboxane synthases. J. Lipid Mediat. Cell Signal. 12:1995;243-255.
11. Shen R.F., Tai H.H. Thromboxanes: synthase and receptors. J. Biomed. Sci. 5:1998;153-172.
12. Dogne J.M., de Leval X., Delarge J., David J.L., Masereel B. New trends in thromboxane and prostacyclin modulators. Curr. Med. Chem. 7:2000;609-628.
13. 2-prostacyclin regulatory system. Biochim. Biophys. Acta. 1532:2001;1-14.
14. Geiger J. Inhibitors of platelet signal transduction as anti-aggregatory drugs. Expert Opin. Investig. Drugs. 10:2001;865-890.
15. Hsu P.Y., Tsai A.L., Kulmacz R.J., Wang L.H. Expression, purification, and spectroscopic characterization of human thromboxane synthase. J. Biol. Chem. 274:1999;762-769.
16. 2 biosynthesis. J. Biol. Chem. 264:1989;141-150.
17. Wang L.H., Tsai A.L., Hsu P.Y. Substrate binding is the rate-limiting step in thromboxane synthase catalysis. J. Biol. Chem. 276:2001;14737-14743.
18. 2 synthase by determination of its substrate analog conformational changes using high resolution NMR technique. J. Biol. Chem. 275:2000;40679-40685.
19. Ullrich V., Brugger R. Prostacyclin and thromboxane synthase: new aspects of hemethiolate catalysis. Angew. Chem. Int. Ed. Engl. 33:1994;1911-1919.
20. Tsai A.L., Berka V., Kulmacz R.J., Wu G., Palmer G. An improved sample packing device for rapid freeze-trap electron paramagnetic resonance spectroscopy kinetic measurements. Anal. Biochem. 264:1998;165-171.
21. Ruan K.H., Milfeld K., Kulmacz R.J., Wu K.K. Comparison of the construction of a 3-D model for human thromboxane synthase using P450cam and BM-3 as templates: implications for the substrate binding pocket. Protein Eng. 7:1994;1345-1351.
22. 2 synthase active site residues by molecular modeling-guided site-directed mutagenesis. J. Biol. Chem. 271:1996;19970-19975.
23. Hsu P.Y., Tsai A.L., Wang L.H. Identification of thromboxane synthase amino acid residues involved in heme-propionate binding. Arch. Biochem. Biophys. 383:2000;119-127.
24. Chevalier D., Lo-Guidice J.M., Sergent E., Allorge D., Debuysere H., Ferrari N.et al. Identification of genetic variants in the human thromboxane synthase gene (CYP5A1). Mutat. Res. Genomics. 432:2000;61-67.
25. 2 production in human monocytes: implications for the use of cyclooxygenase inhibitors. J. Immunol. 165:2000;1605-1611.
26. Caughey G.E., Cleland L.G., Penglis P.S., Gamble J.R., James M.J. Roles of cyclooxygenase (cox)-1 and cox-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by cox-2. J. Immunol. 167:2001;2831-2838.
27. 2. J. Biol. Chem. 276:2001;34918-34927.
28. Miyata A., Yokoyama C., Ihara H., Bandoh S., Takeda O., Takahashi E.et al. Characterization of the human gene (TBXAS1) encoding thromboxane synthase. Eur. J. Biochem. 224:1994;273-279.
29. Baek S.J., Lee K.D., Shen R.F. Genomic structure and polymorphism of the human thromboxane synthase-encoding gene. Gene. 173:1996;251-256.
30. Tazawa R., Green E.D., Ohashi K., Wu K.K., Wang L.H. Characterization of the complete genomic structure of human thromboxane synthase gene and functional analysis of its promoter. Arch. Biochem. Biophys. 334:1996;349-356.
31. Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Suttan G.G.et al. The sequence of the human genome. Science. 291:2001;1304-1351.
32. Schimenti JC. Molecular Evolution of Physiological Processes. In: Fambrough DM, editor. New York: Rockfeller University Press, 1994. p. 85-91.
33. Zhang L., Xiao H., Schultz R.A., Shen R.F. Genomic organization, chromosomal localization, and expression of murine thromboxane synthase gene (Tbxas1). Genomics. 45:1997;519-528.
34. Tsujita Y., Kinoshita M., Tanabe T., Iwai N. Role of a genetic variation in the promoter of human thromboxane synthase gene in myocardial infarction. Atherosclerosis. 153:2000;261-262.
35. Wang L.H., Tazawa R., Lang A.Q., Wu K.K. Alternate splicing of human thromboxane synthase mRNA. Arch. Biochem. Biophys. 315:1994;273-278.
36. Ullrich V., Nusing R. Thromboxane synthase: from isolation to function. Stroke. 21(Suppl IV):1990;134-138.
37. Nusing R., Ullrich V. Regulation of cyclooxygenase and thromboxane synthase in human monocytes. Eur. J. Biochem. 206:1992;131-136.
38. Javahery R., Khachi A., Lo K., Zenzie-Gregory B., Smale S.T. DNA sequence requirements for transcriptional initiator activity in mammalian cells. Mol. Cell. Biol. 14:1994;116-127.
39. Lewis B.A., Orkin S.H. A functional initiator in the human beta-globin promoter. J. Biol. Chem. 270:1995;28139-28144.
40. Lee K.D., Baek S.J., Shen R.F. Multiple factors regulating the expression of human thromboxane synthase gene. Biochem. J. 319:1996;783-791.
41. Chan J.Y., Han X.L., Kan Y.W. Isolation of cDNA encoding the human NF-E2 protein. Proc. Natl. Acad Sci. USA. 90:1993;11366-11370.
42. Andrews N.C., Erdjument-Bromage H., Davidson M.B., Tempst P., Orkin S.H. Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature. 362:1993;722-728.
43. Igarashi K., Kataoka K., Itoh K., Hayashi N., Nishizawa M., Yamamoto M. Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature. 367:1994;568-572.
44. Andrews N.C., Kotkow K.J., Ney P.A., Erdjument-Bromage H., Tempst P., Orkin S.H. The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper related to the v-maf oncogene. Proc. Natl. Acad Sci. USA. 90:1993;11488-11492.
45. Orkin S.H. Transcription factors and hematopoietic development. J. Biol. Chem. 270:1995;4955-4958.
46. Shivdasani R.A., Rosenblatt M.F., Zucker-Franklin D., Jackson C.W., Hunt P., Saris C.J.et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell. 81:1995;695-704.
47. Deveaux S., Cohen-Kaminsky S., Shivdasani R.A., Andrews N.C., Filipe A., Kuzniak I.et al. p45 NF-E2 regulates expression of thromboxane synthase in megakaryocytes. EMBO J. 16:1997;5654-5661.
48. Vitrat N., Letestu R., Masse A., Lazar V., Vainchenker W., Debili N. Thromboxane synthase has the same pattern of expression as platelet specific glycoproteins during human megakaryocyte differentiation. Thromb. Haemost. 83:2000;759-768.
49. Ney P.A., Sorrentino B.P., McDonagh K.T., Nienhuis A.W. Tandem AP-1 binding sites within the human beta-globin dominant control region function as an inducible enhancer in erythroid cells. Genes Dev. 4:1990;993-1006.
50. Caterina J.J., Ryan T.M., Pawlik K.M., Palmiter R.D., Brinster R.L., Behringer R.R.et al. Human beta-globin locus control region analysis of 5′ DNase I hypersensitive site HS 2 in transgenic mice. Proc. Natl. Acad. Sci. USA. 88:1991;1626-1630.
51. Talbot D., Grosveld F. The 5′HS2 of the globin locus control region enhances transcription through the interaction of a multimeric complex binding at two functionally distinct NF-E2 binding sites. EMBO J. 10:1991;1391-1398.
52. Gong Q.H., McDowell J.C., Dean A. Essential role of NF-E2 in remodeling of chromatin structure and transcriptional activation of epsilon-globin gene in vivo by 5′ hypersensitive site 2 of the beta-globin locus control region. Mol. Cell. Biol. 16:1996;6055-6064.
53. Armstrong J.A., Emerson B.M. NF-E2 disrupts chromatin structure at human beta-globin locus control region hypersensitive site 2 in vitro. Mol. Cell. Biol. 16:1996;5634-5644.
54. Chan J.Y., Han X.L., Kan Y.W. Cloning of Nrf1 an NF-E2-related transcription factor, by genetic selection in yeast. Proc. Natl. Acad. Sci. USA. 90:1993;11371-11375.
55. Moi P., Chan K., Asunis I., Cao A., Kan Y.W. Isolation of NF-E2-related factor (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc. Natl. Acad. Sci. USA. 91:1994;9926-9930.
56. Kobayashi A., Ito E., Toki T., Kogame K., Takahashi S., Igarashi K., Hayashi N., Yamamoto M. Molecular cloning and functional characterization of a new cap'n'collar family transcritpion factor, Nrf3. J. Biol. Chem. 274:1999;6443-6452.
57. Oyake T., Itoh K., Motohashi H., Hayashi N., Hoshino H., Nishizawa M., Yamamoto M., Igarashi K. Bach proteins belong to a novel family of BTB-leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16:1996;6083-6095.
58. Ikeda Y., Sugawara A., Taniyama Y., Uruno A., Igagashi K., Arima S., Ito S., Takeuchi K. Suppression of rat thromboxane synthase gene transcription by peroxisome proliferator-activated receptor gamma in macrophages via an interaction with NRF2. J. Biol. Chem. 275:2000;33142-33150.
59. Motohashi H., Katsuoka F., Shavit J.A., Engel J.D., Yamamoto M. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell. 103:2000;865-875.
60. Motohashi H., Shavit J.A., Igarashi K., Yamamoto M., Engel J.D. The world according to Maf. Nucleic Acid Res. 25:1997;2953-2959.